SUPRIYANSESupriya Lifescience Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Mon, 9 Feb, 2026 · 19:25 IST

Supriya Lifescience Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.

SUPRIYA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.0%Reaction day
₹686.10
prior close
₹650.00
announcement price
After-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+1.0%-1.0% vs market
Pharmaceuticals peers, median of 159sector+0.4%-0.4% vs sector

On the reaction day the stock moved 1.0 pts less than Nifty Microcap 250 and 0.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+3.1
10m
+4.9
15m
+6.1
30m
+5.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.0+1.0-1.0+0.4-0.4
Next day
+3.3+0.5+2.8+0.2+3.1
2d
+0.6-0.0+0.7-0.0+0.7
3d
-0.8-1.5+0.7-1.2+0.5
4d
-1.7-2.2+0.5-1.8+0.1
5d
-1.9-1.2-0.7-1.8-0.1
1w
-0.2-2.4+2.2-2.6+2.4
15d
-10.2-8.8-1.4-6.9-3.3
1m
-11.8-8.3-3.5-5.1-6.7
2m
-6.9-3.5-3.4-3.3-3.6
3m
+5.2+6.4-1.2+2.8+2.5
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Supriya Lifescience Limited has submitted its financial results for the quarter and period ended December 31, 2025 to the stock exchange. The announcement is a routine regulatory filing under SEBI's listing obligations and does not include detailed numbers in the headline. Investors will need to review the full results document to assess revenue, profit, margins, and other key metrics. No specific figures, growth rates, or auditor observations are visible in the provided excerpt.

Likely market impact

This is a standard compliance filing, not an event-driven announcement. Any meaningful impact on the stock or shareholders will depend on the actual numbers in the full results — particularly revenue growth, PAT movement, and margin trends versus previous quarters.